Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
Part of paid clinical trials in Irvine, California.
- Sponsor
- Ray Therapeutics, Inc.
- Study ID
- NCT06375239
- Status
- Recruiting
Conditions
- Choroideremia
- Geographic Atrophy from Age-related Macular Degeneration
- Retinal Dystrophies
- Retinitis Pigmentosa
- Stargardt Disease
- Stargardt Macular Dystrophy
- X-lined Retinoschisis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
Key Dates
- Start date
- Apr 5, 2024
- Status verified
- Jan 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 120 participants (estimated)
Arms
- Arm: Retinitis PigmentosaUp to 40 patients with Retinitis Pigmentosa
- Arm: ChoroideremiaUp to 40 patients with Choroideremia
- Arm: Stargardt Macular Dystrophy (Stargardt Disease)Up to 40 patients with Stargardt Macular Dystrophy also known as Stargardt Disease
- Arm: Geographic Atrophy from Age-related Macular DegenerationUp to 40 patients with Geographic Atrophy from Age-related Macular Degeneration
- Arm: X-linked RetinoschisisUp to 40 patients with X-linked Retinoschisis
- Arm: Other Retinal DystrophiesUp to 40 patients with other retinal dystrophies
Primary Outcome Measure
Operational feasibility of testing moderate to profound vision impaired patients with various retinal dystrophies on a battery of visual assessments [ Time Frame: 3 months ]
Central Contacts
- Shawn Yu, OD949-264-3793
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vision Research and Assessment Institute | Irvine | California | 92612 |
Find similar trials in Irvine, CA
By research site
Related Studies
- Retinal Imaging in Patients With Inherited Retinal DegenerationsRecruiting · University of California, San Francisco · San Francisco, California
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt DiseasePHASE2 · Enrolling By Invitation · Alkeus Pharmaceuticals, Inc. · Phoenix, Arizona
- Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis PigmentosaPHASE3 · Enrolling By Invitation · NightstaRx Ltd, a Biogen Company · Los Angeles, California
- EyeConic: Qualification for Cone-OptogeneticsRecruiting · Institute of Molecular and Clinical Ophthalmology Basel · San Francisco, California